FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 315:559-563 August 28, 1986 Number 9 Next

	Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Abstract

We analyzed the relation between age at diagnosis and relative survival (ratio of observed to expected survival) in 57,068 women in Sweden in whom breast cancer was diagnosed in 1960 to 1978 (about 98 percent of all cases). Women who were 45 to 49 years old had the best prognosis, with a relative survival exceeding that of the youngest patients (less than 30 years) by 7.6 to 12.9 percent at different periods of observation. Relative survival declined markedly after the age of 49--particularly in women aged 50 to 59--and the oldest women (greater than 75) had the worst rate. The difference in relative survival between those older than 75 and those 45 to 49 increased from 8.6 percent at 2 years to 12.2, 20.3, and 27.5 percent after 5, 10, and 15 years of follow-up, respectively. The long-term annual mortality rate due to breast cancer approached 1 to 2 percent at the premenopausal ages but exceeded 5 percent throughout the period of observation in the oldest age group. An understanding of the biologic basis for the complex relation between age and prognosis might provide a better understanding of the natural history of breast cancer in women.

This article has been cited by other articles:

• Okonkwo, Q. L., Draisma, G., der Kinderen, A., Brown, M. L., de Koning, H. J. (2008). Breast Cancer Screening Policies in Developing Countries: A Cost-effectiveness Analysis for India. JNCI J Natl Cancer Inst 100: 1290-1300 [Abstract] [Full Text]  
• Anders, C. K., Hsu, D. S., Broadwater, G., Acharya, C. R., Foekens, J. A., Zhang, Y., Wang, Y., Marcom, P. K., Marks, J. R., Febbo, P. G., Nevins, J. R., Potti, A., Blackwell, K. L. (2008). Young Age at Diagnosis Correlates With Worse Prognosis and Defines a Subset of Breast Cancers With Shared Patterns of Gene Expression. JCO 26: 3324-3330 [Abstract] [Full Text]  
• Aebi, S, Castiglione, M (2006). The enigma of young age.. Ann Oncol 17: 1475-1477 [Full Text]  
• Krop, I. E., Winer, E. P. (2005). Ovarian Suppression for Breast Cancer: An Effective Treatment in Search of a Home. JCO 23: 5869-5872 [Full Text]  
• Prowell, T. M., Davidson, N. E. (2004). What Is the Role of Ovarian Ablation in the Management of Primary and Metastatic Breast Cancer Today?. The Oncologist 9: 507-517 [Abstract] [Full Text]  
• Brenner, H., Hakulinen, T. (2004). Are Patients Diagnosed With Breast Cancer Before Age 50 Years Ever Cured?. JCO 22: 432-438 [Abstract] [Full Text]  
• Goldhirsch, A., Wood, W. C., Gelber, R. D., Coates, A. S., Thurlimann, B., Senn, H.-J. (2003). Meeting Highlights: Updated International Expert Consensus on the Primary Therapy of Early Breast Cancer. JCO 21: 3357-3365 [Abstract] [Full Text]  
• Wulfkuhle, J. D., Sgroi, D. C., Krutzsch, H., McLean, K., McGarvey, K., Knowlton, M., Chen, S., Shu, H., Sahin, A., Kurek, R., Wallwiener, D., Merino, M. J., Petricoin, E. F. III, Zhao, Y., Steeg, P. S. (2002). Proteomics of Human Breast Ductal Carcinoma in Situ. Cancer Res. 62: 6740-6749 [Abstract] [Full Text]  
• Colleoni, M., Rotmensz, N., Robertson, C., Orlando, L., Viale, G., Renne, G., Luini, A., Veronesi, P., Intra, M., Orecchia, R., Catalano, G., Galimberti, V., Nole, F., Martinelli, G., Goldhirsch, A. (2002). Very young women (<35 years) with operable breast cancer: features of disease at presentation. Ann Oncol 13: 273-279 [Abstract] [Full Text]  
• Goldhirsch, A., Gelber, R. D., Yothers, G., Gray, R. J., Green, S., Bryant, J., Gelber, S., Castiglione-Gertsch, M., Coates, A. S. (2001). Adjuvant Therapy for Very Young Women With Breast Cancer: Need for Tailored Treatments. J Natl Cancer Inst Monogr 2001: 44-51 [Abstract] [Full Text]  
• Wärnberg, F., Bergh, J., Zack, M., Holmberg, L. (2001). Risk Factors for Subsequent Invasive Breast Cancer and Breast Cancer Death after Ductal Carcinoma in Situ: A Population-based Case-Control Study in Sweden. Cancer Epidemiol. Biomarkers Prev. 10: 495-499 [Abstract] [Full Text]  
• Loprinzi, C. L., Thome, S. D. (2001). Understanding the Utility of Adjuvant Systemic Therapy for Primary Breast Cancer. JCO 19: 972-979 [Abstract] [Full Text]  
• Diab, S. G., Elledge, R. M., Clark, G. M. (2000). Tumor Characteristics and Clinical Outcome of Elderly Women With Breast Cancer. JNCI J Natl Cancer Inst 92: 550-556 [Abstract] [Full Text]  
• Kroman, N., Jensen, M.-B., Wohlfahrt, J., Mouridsen, H. T, Andersen, P. K., Melbye, M., Tutt, A., Ross, G. (2000). Factors influencing the effect of age on prognosis in breast cancer: population based study • Commentary: much still to learn about relations between tumour biology, prognosis, and treatment outcome in early breast cancer. BMJ 320: 474-479 [Abstract] [Full Text]  
• Wärnberg, F., Bergh, J., Holmberg, L. (1999). Prognosis in Women with a Carcinoma in Situ of the Breast: A Population-based Study in Sweden. Cancer Epidemiol. Biomarkers Prev. 8: 769-774 [Abstract] [Full Text]  
• Olivotto, I. A., Kan, L., Coldman, A. J., Paci, E., Giorgi, D., del Turco, M. R., Roux, S., Markle, L., Diamond, A., Sickles, E. A., Fishbein, M., Gross, T. L., Kopans, D. B., Feig, S. A., Elmore, J. G., Barton, M. B., Arena, P. J., Sox, H. C. (1998). False Positive Rate of Screening Mammography. NEJM 339: 560-564 [Full Text]  
• Gattuso, P., Bloom, K., Yaremko, L., Borok, R., Cobleigh, M., Madsen, K., Gould, V. E., Reddy, V. (1998). Marker Panel Predictive of Lymph Node Metastasis in Young Patients with Breast Carcinoma. INT J SURG PATHOL 6: 55-60 [Abstract]